05/09/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:30 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
5:10 AM | Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
04/01/2024
5:15 AM | Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
03/26/2024
3:05 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
01/26/2024
3:00 PM | Phathom Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/26/2024
3:00 PM | Medicxi Growth I LP (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
5:13 AM | Phathom Pharmaceuticals (Issuer)
TAKEDA PHARMACEUTICAL CO LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
5:11 AM | Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
01/22/2024
7:19 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
7:21 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
7:22 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
3:40 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2023
11:15 PM | Phathom Pharmaceuticals (Filer)
| Form EFFECT | |
11/09/2023
3:02 PM | Phathom Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/09/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
6:56 PM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:53 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:54 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:55 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
7:07 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/21/2023
7:30 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4/A | |
07/17/2023
4:00 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
4:00 PM | Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
4:00 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
3:02 PM | Phathom Pharmaceuticals (Subject)
| Form SC TO-I/A | |
07/17/2023
3:04 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
8:10 AM | Phathom Pharmaceuticals (Subject)
| Form SC TO-C | |
06/15/2023
8:01 AM | Phathom Pharmaceuticals (Subject)
| Form SC TO-I | |
06/15/2023
8:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
5:32 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad) Right now, there’s over $6 trillion in potential investment money waiting on the sidelines.
That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… |
06/05/2023
5:37 PM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
5:46 PM | COLA MICHAEL F (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
5:48 PM | KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
5:53 PM | FIELDS HEIDI (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
5:55 PM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
5:57 PM | Phathom Pharmaceuticals (Issuer)
Socks David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
6:01 PM | Phathom Pharmaceuticals (Issuer)
Stenhouse Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
6:03 PM | Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
4:16 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/26/2023
4:29 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13D/A | |
05/24/2023
3:11 PM | Phathom Pharmaceuticals (Filer)
| Form 424B5 | |
05/24/2023
3:14 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
3:47 PM | Phathom Pharmaceuticals (Filer)
| Form 424B5 | |
05/23/2023
3:03 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
11:15 AM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
